Corporate Governance
The Board of Directors of OncoGenex Pharmaceuticals, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
| Document | View | ||
|---|---|---|---|
| Code of Business Conduct and Ethics |
51.0 KB
|
|
|
| Charter of the Audit Committee |
97.1 KB
|
|
|
| Charter of the Compensation Committee |
34.0 KB
|
|
|
| Charter of the Nominating and Governance Committee |
42.7 KB
|
|
|
| Whistle Blowing Policy |
33.8 KB
|
|
|
| Regulation FD Policy |
20.7 KB
|
|
|
= add file to Briefcase
About OncoGeneX
For Patients
For Physicians
For Investors
Careers With Us
Investors
SHAREHOLDER TOOLS

© 2004-2011 OncoGenex Pharmaceuticals Inc. All rights reserved.
OncoGenex product candidates are investigational drugs for use only in approved clinical trials.
About OncoGenex
OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.
For Patients
OncoGenex is uniquely focused on the challenge of cancer treatment resistance. We currently have several on-going clinical trials that may be of interest to you.
For Physicians
OncoGenex focuses on diverse molecular entities that target mechanisms of resistance and that have the potential to re-define treatment paradigms in a variety of cancers.




